# Treatment of Tinnitus With Olanzapine

> **NCT07190482** · PHASE1 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 50 (actual)

## Conditions studied

- Tinnitus
- Tinnitus, Subjective

## Interventions

- **DRUG:** Olanzapine 5 Mg ORAL TABLET
- **DRUG:** Placebo Drug

## Key facts

- **NCT ID:** NCT07190482
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-01
- **Primary completion:** 2024-12-20
- **Final completion:** 2025-01-20
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07190482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07190482, "Treatment of Tinnitus With Olanzapine". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07190482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*